{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:32:47Z","timestamp":1761197567005,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,7,6]]},"abstract":"<jats:p>Dementia with Lewy bodies (DLB) is the second most common neurodegenerative dementia associated with poor prognosis and high carers\u2019 burden. Neuropsychiatric symptoms worsen this prognosis and are a high source of distress for service users and their carers. However, there is currently insufficient evidence to support the pharmacological and non-pharmacological management of these symptoms. Acetylcholinesterase inhibitors are the first-line pharmacological option, but challenging risky behaviours may persist despite their use. Antipsychotic medications are indicated in such clinical scenarios, but there is very limited evidence to support the efficacy and safety of these medications for managing neuropsychiatric symptoms in DLB. Hence, we report an individual with DLB with severe distressing persistent visual hallucinations and agitation. After multiple treatment options had failed, clozapine was successfully initiated with substantial improvement in both clinical and functional outcomes. Further studies are warranted for evaluating the efficacy of clozapine in managing neuropsychiatric symptoms in DLB.<\/jats:p>","DOI":"10.1136\/bcr-2018-224710","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:25:18Z","timestamp":1532651118000},"page":"bcr-2018-224710","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Successful management of persistent distressing neuropsychiatric symptoms by clozapine in a patient suffering from dementia with Lewy bodies"],"prefix":"10.1136","volume":"2018","author":[{"given":"Manraj","family":"Bhamra","sequence":"first","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-6326","authenticated-orcid":false,"given":"Anto P","family":"Rajkumar","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic H","family":"Ffytche","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Kalafatis","sequence":"additional","affiliation":[{"name":"Maudsley Hospital, South London and Maudsley NHS Foundation Trust, London, UK"},{"name":"Department of Old Age Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afi190"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00462-6"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1474-4422(17)30074-1","article-title":"The prognosis of dementia with Lewy bodies","volume":"16","author":"Mueller","year":"2017","journal-title":"Lancet Neurol"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14121582"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11910-017-0778-2","article-title":"New therapeutic strategies for lewy body dementias","volume":"17","author":"Velayudhan","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610217002010","article-title":"Systematic review of the efficacy of non-pharmacological interventions in people with Lewy body dementia","volume":"30","author":"Morrin","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4938154","article-title":"The efficacy and safety of antipsychotic medications in the treatment of psychosis in patients with parkinson\u2019s disease","volume":"2016","author":"Divac","year":"2016","journal-title":"Behav Neurol"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.9","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000260060.60870.89"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)00860-0"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199903113401003"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.12","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1017\/S1041610210000190","article-title":"Adjunct treatment with levodopa in a patient with dementia with Lewy bodies, delusions and severe neuroleptic hypersensitivity syndrome","volume":"22","author":"Majic","year":"2010","journal-title":"Int Psychogeriatr"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.13","doi-asserted-by":"publisher","DOI":"10.1176\/jnp.5.2.206"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1176\/jnp.10.2.227","article-title":"Neuroleptic sensitivity to clozapine in dementia with Lewy bodies","volume":"10","author":"Burke","year":"1998","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.15","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.176"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62106-6"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(18)30039-5","article-title":"Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer\u2019s disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study","volume":"17","author":"Ballard","year":"2018","journal-title":"Lancet Neurol"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40266-013-0144-2","article-title":"Adverse effects of clozapine in older patients: epidemiology, prevention and management","volume":"31","author":"Bishara","year":"2014","journal-title":"Drugs Aging"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8213165","article-title":"Influence of antipsychotic and anticholinergic loads on cognitive functions in patients with schizophrenia","volume":"2016","author":"Rehse","year":"2016","journal-title":"Schizophr Res Treatment"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.20","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.21","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.48.5_suppl_6.10s"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.22","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1965"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.23","doi-asserted-by":"publisher","DOI":"10.1159\/000200107"},{"key":"2025082700133168000_2018.jul25_2.bcr-2018-224710.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02052.x"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-224710","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T07:13:41Z","timestamp":1756278821000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-224710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":24,"alternative-id":["10.1136\/bcr-2018-224710"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-224710","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}